What is the appropriate management for Dexilant (dexlansoprazole)-induced diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Dexilant-Induced Diarrhea

Discontinue Dexilant immediately if diarrhea develops, as this is a recognized adverse effect of the medication, and consider switching to an alternative acid suppression strategy if ongoing treatment is necessary.

Understanding the Problem

Diarrhea is a well-documented adverse effect of dexlansoprazole (Dexilant), occurring in approximately 5-12% of patients across clinical trials 1, 2, 3, 4. The FDA label explicitly warns about Clostridium difficile-associated diarrhea as a serious complication of PPI therapy 1. While most drug-induced diarrhea from PPIs is mild and self-limited 5, the primary management strategy is identifying and removing the causative agent.

Immediate Management Steps

1. Assess Severity and Rule Out Complications

Evaluate for warning signs that indicate complicated diarrhea requiring aggressive intervention:

  • Fever (suggests possible C. difficile infection)
  • Severe cramping or abdominal pain
  • Blood in stool
  • Signs of dehydration (dizziness on standing, decreased urine output)
  • Duration and frequency of diarrhea

If any of these are present, this becomes a complicated case requiring more aggressive evaluation 6.

2. Stop the Offending Medication

Discontinue Dexilant as the first-line intervention 1. The FDA label specifically instructs patients to "call your doctor right away if you have watery stool, stomach pain, and fever that does not go away" 1.

3. Rule Out C. difficile Infection

Given that PPI therapy increases risk of C. difficile-associated diarrhea 1, consider stool testing for C. difficile toxin if:

  • Diarrhea is severe or persistent
  • Patient has fever
  • Patient was recently hospitalized or received antibiotics
  • Symptoms do not improve after stopping Dexilant

The diagnosis "should be considered for diarrhea that does not improve" 1.

Symptomatic Treatment (If Uncomplicated)

For mild, uncomplicated diarrhea without fever or bloody stools:

Dietary Modifications

  • Eliminate lactose-containing products immediately 6
  • Avoid alcohol and high-osmolar supplements 6
  • Increase clear fluid intake: 8-10 large glasses daily (electrolyte solutions like sports drinks or broth) 6
  • Eat frequent small meals: bananas, rice, applesauce, toast, plain pasta (BRAT diet) 6

Oral Rehydration

  • Use reduced osmolarity oral rehydration solution (ORS) for mild to moderate dehydration 7
  • This is first-line therapy with strong evidence 7

Antidiarrheal Agents (Use Cautiously)

  • Loperamide may be considered in immunocompetent adults with uncomplicated watery diarrhea 7

    • Initial dose: 4 mg, then 2 mg every 4 hours or after each unformed stool
    • Maximum: 16 mg/day 8, 6
    • Do NOT use if fever, bloody stools, or severe abdominal pain present 7
  • Probiotics may reduce symptom severity and duration 7

When to Escalate Care

Seek immediate medical evaluation if:

  • Diarrhea persists >48 hours after stopping Dexilant
  • Development of fever, bloody stools, or severe dehydration
  • Signs of acute kidney injury (decreased urine output, blood in urine) 1
  • Severe dehydration requiring IV fluids 7

Alternative Acid Suppression Strategy

If ongoing acid suppression is medically necessary after stopping Dexilant:

  1. Wait for diarrhea to resolve completely before restarting any PPI
  2. Consider alternative approaches:
    • Different PPI with potentially lower diarrhea risk (though all PPIs carry this risk)
    • H2-receptor antagonists as alternative
    • Non-pharmacologic measures (dietary modifications, head of bed elevation)
  3. Use the lowest effective dose for the shortest duration necessary 1

Critical Pitfalls to Avoid

  • Do not continue Dexilant hoping symptoms will resolve spontaneously
  • Do not use antimotility agents if there is any suspicion of inflammatory diarrhea or C. difficile infection 7
  • Do not ignore persistent diarrhea - it may indicate C. difficile infection requiring specific antibiotic therapy
  • Do not restart the same medication without addressing the underlying cause of diarrhea

The evidence clearly supports medication discontinuation as the primary intervention for drug-induced diarrhea 5, 9, with symptomatic management serving only as adjunctive therapy while the causative agent is eliminated.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.